FIXX Annual CFF
$184.00 K
-$412.00 K-69.13%
01 December 2023
Summary:
As of January 21, 2025, FIXX annual cash flow from financing activities is $184.00 thousand, with the most recent change of -$412.00 thousand (-69.13%) on December 1, 2023. During the last 3 years, it has fallen by -$52.91 million (-99.65%).FIXX Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FIXX Quarterly CFF
$14.00 K
-$4000.00-22.22%
01 December 2023
Summary:
As of January 21, 2025, FIXX quarterly cash flow from financing activities is $14.00 thousand, with the most recent change of -$4000.00 (-22.22%) on December 1, 2023. Over the past year, it has dropped by -$4000.00 (-22.22%).FIXX Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FIXX TTM CFF
$184.00 K
-$18.00 K-8.91%
01 December 2023
Summary:
As of January 21, 2025, FIXX TTM cash flow from financing activities is $184.00 thousand, with the most recent change of -$18.00 thousand (-8.91%) on December 1, 2023. Over the past year, it has dropped by -$18.00 thousand (-8.91%).FIXX TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FIXX Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -69.1% | -22.2% | -8.9% |
| 3 y3 years | -99.7% | -22.2% | -8.9% |
| 5 y5 years | -99.9% | -22.2% | -8.9% |
FIXX Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | -99.9% | -100.0% | -99.9% |
Homology Medicines Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | $184.00 K(-69.1%) | $14.00 K(-22.2%) | $184.00 K(-8.9%) |
| Sept 2023 | - | $18.00 K(+800.0%) | $202.00 K(-34.4%) |
| June 2023 | - | $2000.00(-98.7%) | $308.00 K(+0.7%) |
| Mar 2023 | - | $150.00 K(+368.8%) | $306.00 K(-48.7%) |
| Dec 2022 | $596.00 K(-98.9%) | $32.00 K(-74.2%) | $596.00 K(+5.5%) |
| Sept 2022 | - | $124.00 K(>+9900.0%) | $565.00 K(-31.1%) |
| June 2022 | - | $0.00(-100.0%) | $820.00 K(-98.4%) |
| Mar 2022 | - | $440.00 K(>+9900.0%) | $50.57 M(-3.1%) |
| Dec 2021 | $52.17 M(-1.7%) | $1000.00(-99.7%) | $52.17 M(-49.9%) |
| Sept 2021 | - | $379.00 K(-99.2%) | $104.16 M(-0.0%) |
| June 2021 | - | $49.75 M(+2334.9%) | $104.19 M(+90.5%) |
| Mar 2021 | - | $2.04 M(-96.1%) | $54.69 M(+3.0%) |
| Dec 2020 | $53.09 M | $51.99 M(>+9900.0%) | $53.09 M(+124.3%) |
| Sept 2020 | - | $410.00 K(+70.1%) | $23.67 M(-0.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2020 | - | $241.00 K(-46.1%) | $23.88 M(-84.9%) |
| Mar 2020 | - | $447.00 K(-98.0%) | $158.34 M(+0.1%) |
| Dec 2019 | $158.21 M(+4.8%) | $22.57 M(+3576.7%) | $158.21 M(+16.6%) |
| Sept 2019 | - | $614.00 K(-99.5%) | $135.68 M(+0.4%) |
| June 2019 | - | $134.70 M(>+9900.0%) | $135.09 M(-11.3%) |
| Mar 2019 | - | $325.00 K(+692.7%) | $152.28 M(+0.8%) |
| Dec 2018 | $150.99 M(+31.0%) | $41.00 K(+64.0%) | $150.99 M(-7.1%) |
| Sept 2018 | - | $25.00 K(-100.0%) | $162.62 M(-33.8%) |
| June 2018 | - | $151.89 M(<-9900.0%) | $245.68 M(+161.9%) |
| Mar 2018 | - | -$958.00 K(-108.2%) | $93.79 M(-18.6%) |
| Dec 2017 | $115.23 M(>+9900.0%) | $11.66 M(-86.0%) | $115.23 M(+11.3%) |
| Sept 2017 | - | $83.09 M(>+9900.0%) | $103.57 M(+405.7%) |
| June 2017 | - | $0.00(-100.0%) | $20.48 M(0.0%) |
| Mar 2017 | - | $20.48 M | $20.48 M |
| Dec 2016 | $378.30 K | - | - |
FAQ
- What is Homology Medicines annual cash flow from financing activities?
- What is the all time high annual CFF for Homology Medicines?
- What is Homology Medicines annual CFF year-on-year change?
- What is Homology Medicines quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Homology Medicines?
- What is Homology Medicines quarterly CFF year-on-year change?
- What is Homology Medicines TTM cash flow from financing activities?
- What is the all time high TTM CFF for Homology Medicines?
- What is Homology Medicines TTM CFF year-on-year change?
What is Homology Medicines annual cash flow from financing activities?
The current annual CFF of FIXX is $184.00 K
What is the all time high annual CFF for Homology Medicines?
Homology Medicines all-time high annual cash flow from financing activities is $158.21 M
What is Homology Medicines annual CFF year-on-year change?
Over the past year, FIXX annual cash flow from financing activities has changed by -$412.00 K (-69.13%)
What is Homology Medicines quarterly cash flow from financing activities?
The current quarterly CFF of FIXX is $14.00 K
What is the all time high quarterly CFF for Homology Medicines?
Homology Medicines all-time high quarterly cash flow from financing activities is $151.89 M
What is Homology Medicines quarterly CFF year-on-year change?
Over the past year, FIXX quarterly cash flow from financing activities has changed by -$4000.00 (-22.22%)
What is Homology Medicines TTM cash flow from financing activities?
The current TTM CFF of FIXX is $184.00 K
What is the all time high TTM CFF for Homology Medicines?
Homology Medicines all-time high TTM cash flow from financing activities is $245.68 M
What is Homology Medicines TTM CFF year-on-year change?
Over the past year, FIXX TTM cash flow from financing activities has changed by -$18.00 K (-8.91%)